CW
CRSP icon

CreativeOne Wealth’s CRISPR Therapeutics CRSP Stock Holding History

CreativeOne Wealth’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,234
Closed -$222K – 1192
2025
Q4 		$222K Buy
+4,234
New +$254K 0.01% 1079
2025
Q3 		– Sell
-4,775
Closed -$232K – 1158
2025
Q2 		$232K Buy
+4,775
New +$185K 0.01% 1011
2021
Q4 		– Sell
-1,962
Closed -$220K – 756
2021
Q3 		$220K Hold
1,962
– – 0.01% 642
2021
Q2 		$318K Sell
1,962
-5,785
-75% -$704K 0.02% 516
2021
Q1 		$944K Buy
7,747
+1,239
+19% +$187K 0.07% 213
2020
Q4 		$996K Buy
+6,508
New +$769K 0.08% 186

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

CreativeOne Wealth's CRSP Position: Q1 2026 in Review

CreativeOne Wealth sold out of CRISPR Therapeutics (CRSP) in Q1 2026, closing a stake of 4,234 shares — an estimated $222K sold.

CreativeOne Wealth first reported a position in CRSP in Q4 2020 and held it in 6 quarters. The position peaked at $996K in Q4 2020. 492 funds tracked by Wall St. Rank hold CRSP as of Q1 2026.

  • CreativeOne Wealth reported no remaining CRISPR Therapeutics position as of Q1 2026 after selling out during the quarter.
  • CreativeOne Wealth sold 4,234 CRISPR Therapeutics shares in Q1 2026, an estimated $222K.
  • CreativeOne Wealth first reported a position in CRISPR Therapeutics in Q4 2020 and held it in 6 quarters.
  • CreativeOne Wealth's CRISPR Therapeutics position peaked at $996K in Q4 2020.
  • 492 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q1 2026.

Based on CreativeOne Wealth's 13F filing for Q1 2026, filed 15 May 2026.